(NASDAQ: IOSP) Innospec's forecast annual revenue growth rate of -2.75% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 0.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.22%.
Innospec's revenue in 2024 is $1,894,000,000.On average, 2 Wall Street analysts forecast IOSP's revenue for 2024 to be $45,942,097,482, with the lowest IOSP revenue forecast at $45,543,034,746, and the highest IOSP revenue forecast at $46,341,160,218.
In 2025, IOSP is forecast to generate $48,398,827,451 in revenue, with the lowest revenue forecast at $47,588,231,268 and the highest revenue forecast at $49,209,423,633.